Pfizer Inc. (NYSE: PFE) is -4.03% lower on its value in year-to-date trading and has touched a low of $25.61 and a high of $42.22 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The PFE stock was last observed hovering at around $27.72 in the last trading session, with the day’s loss setting it -0.09%.
Currently trading at $27.63, the stock is 1.14% and -0.12% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 29.0 million and changing -0.32% at the moment leaves the stock -13.81% off its SMA200. PFE registered -31.10% loss for a year compared to 6-month loss of -17.87%. The firm has a 50-day simple moving average (SMA 50) of $3.68 and a 200-day simple moving average (SMA200) of $22.51.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 0.04% gain in the last 1 month and extending the period to 3 months gives it a 3.76%, and is -1.36% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.66% over the week and 2.00% over the month.
Pfizer Inc. (PFE) has around 88000 employees, a market worth around $156.02B and $58.50B in sales. Current P/E ratio is 76.88 and Fwd P/E is 10.16. Profit margin for the company is 3.65%. Distance from 52-week low is 7.89% and -34.56% from its 52-week high. The company has generated returns on investments over the last 12 months (1.39%).
Pfizer Inc. quarterly earnings per share for the current quarter are estimated at $0.54 with sales reaching $14.4B over the same period.The EPS is expected to grow by 20.52% this year, but quarterly earnings will post 2.60% year-over-year. Quarterly sales are estimated to shrink -13.20% in year-over-year returns.
Pfizer Inc. (PFE) Top Institutional Holders
3,691 institutions hold shares in Pfizer Inc. (PFE), with institutional investors hold 70.00% of the company’s shares. The shares outstanding are 5.65B, and float is at 5.64B with Short Float at 1.17%. Institutions hold 69.96% of the Float.
The top institutional shareholder in the company is Vanguard Group Inc with over 508.09 million shares valued at $18.64 billion. The investor’s holdings represent 9.00% of the PFE Shares outstanding. As of Jun 29, 2023, the second largest holder is Blackrock Inc. with 445.15 million shares valued at $16.33 billion to account for 7.88% of the shares outstanding. The other top investors are State Street Corporation which holds 287.2 million shares representing 5.09% and valued at over $10.53 billion, while Wellington Management Group, LLP holds 4.13% of the shares totaling 233.11 million with a market value of $8.55 billion.
Pfizer Inc. (PFE) Insider Activity
The most recent transaction is an insider purchase by Gottlieb Scott,the company’sDirector. SEC filings show that Gottlieb Scott bought 3,000 shares of the company’s common stock on Dec 15 ’23 at a price of $26.47 per share for a total of $79401.0. Following the purchase, the insider now owns 9000.0 shares.
Pfizer Inc. disclosed in a document filed with the SEC on May 08 ’23 that Gottlieb Scott (Director) bought a total of 1,000 shares of the company’s common stock. The trade occurred on May 08 ’23 and was made at $38.58 per share for $38580.0. Following the transaction, the insider now directly holds 6000.0 shares of the PFE stock.
Still, SEC filings show that on May 05 ’23, Gottlieb Scott (Director) acquired 1,000 shares at an average price of $38.42 for $38425.0. The insider now directly holds 5,000 shares of Pfizer Inc. (PFE).
